Allianz Asset Management Gmb H Corcept Therapeutics Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 156,400 shares of CORT stock, worth $7.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,400

Previous 181,757 13.95%

Holding current value

$7.8 Million

Previous $5.91 Million 22.52%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$29.51 - $46.26 $748,285 - $1.17 Million	-25,357 Reduced 13.95%	156,400 $7.24 Million
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $425,010 - $659,809	-19,136 Reduced 9.53%	181,757 $5.91 Million
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $3.21 Million - $4.18 Million	152,075 Added 311.51%	200,893 $5.06 Million
Q4 2023 Feb 12, 2024	BUY	$24.82 - $32.88 $407,594 - $539,955	16,422 Added 50.69%	48,818 $1.59 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $22,145 - $34,070	-1,008 Reduced 3.02%	32,396 $882,000
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $203,594 - $238,824	-9,496 Reduced 22.14%	33,404 $743,000
Q1 2023 May 11, 2023	BUY	$19.2 - $24.47 $613,056 - $781,327	31,930 Added 291.07%	42,900 $929,000
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $218,851 - $328,661	10,970 New	10,970 $222,000
Q3 2021 Nov 10, 2021	SELL	$19.68 - $22.53 $660,283 - $755,904	-33,551 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $3.61 Million - $4.42 Million	-180,874 Reduced 84.35%	33,551 $738,000
Q1 2021 May 13, 2021	BUY	$23.49 - $30.56 $4.39 Million - $5.72 Million	187,091 Added 684.46%	214,425 $5.1 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $161,188 - $262,243	-9,606 Reduced 26.0%	27,334 $715,000
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $37,978 - $60,899	-3,048 Reduced 7.62%	36,940 $643,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $439,868 - $730,180	39,988 New	39,988 $672,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $1.21 Million - $1.54 Million	-98,450 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$15.3 - $19.69 $1.22 Million - $1.57 Million	79,565 Added 421.31%	98,450 $1.55 Million
Q1 2018 May 14, 2018	SELL	$14.59 - $25.5 $587,174 - $1.03 Million	-40,245 Reduced 68.06%	18,885 $311,000
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $39,661 - $52,110	-2,515 Reduced 4.08%	59,130 $1.07 Million
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $525,948 - $825,268	42,760 Added 226.42%	61,645 $1.19 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-119,495 Reduced 86.35%	18,885 $224,000
Q1 2017 Apr 17, 2019	SELL	N/A	-733 Reduced 0.53%	138,380 $1.52 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-18,167 Reduced 11.55%	139,113 $1.01 Million
Q3 2016 Apr 17, 2019	BUY	N/A	157,280	157,280 $1.02 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.34B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Corcept Therapeutics Inc Transaction History